thiazoles has been researched along with Carcinoma, Neuroendocrine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gestwicki, JE; Hong, SK; Johnson, OT; Park, JI; Starenki, D | 1 |
| Sabra, MM; Sherman, EJ; Tuttle, RM; Yeh, T; Yeung, M | 1 |
| Armenia, E; Aurilio, C; Barbarisi, A; Barbarisi, M; Clemente, O; de Sena, G; Quagliariello, V; Rosso, F | 1 |
3 other study(ies) available for thiazoles and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Analogs of the Heat Shock Protein 70 Inhibitor MKT-077 Suppress Medullary Thyroid Carcinoma Cells.
Topics: Animals; Carcinoma, Neuroendocrine; Cell Line, Tumor; HSP70 Heat-Shock Proteins; Humans; Mice; Pyridines; Thiazoles; Thyroid Neoplasms | 2022 |
Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies.
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Disease Progression; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Prognosis; Retrospective Studies; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2020 |
New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Aurora Kinase A; Aurora Kinase B; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Cytokines; Dose-Response Relationship, Drug; Drug Carriers; Drug Synergism; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hydrogels; Inhibitory Concentration 50; Phenylurea Compounds; Protein Kinase Inhibitors; Quercetin; Thiazoles; Thyroid Cancer, Papillary; Thyroid Neoplasms; Time Factors | 2016 |